Acurx Pharmaceuticals (ACXP) Tops Q4 EPS by 1c
Tweet
Share
E-mailGet Alerts ACXP Hot Sheet
Join SI Premium – FREE
Acurx Pharmaceuticals (NASDAQ: ACXP) reported Q4 EPS of ($0.28), $0.01 better than the analyst estimate of ($0.29).
For earnings history and earnings-related data on Acurx Pharmaceuticals (ACXP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
- Beam Global (BEEM) Tops Q2 EPS by 8c
- FOMC minutes from July 28-29th meeting
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
